Corcept Therapeutics (CORT) is down -15.0%, or -$13.26 to $75.11.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics Board Member Resigns, Continues as Consultant
- Corcept Therapeutics management to meet with Truist
- 3 ‘Outperform’ Healthcare Stocks, According to AI Analyst, 9/10/25
- Corcept Therapeutics price target raised to $140 from $137 at Canaccord
- Corcept Therapeutics’ New Drug Application Accepted by FDA